Encompass Health Corp/ US29261A1007 /
| 2024-05-16 6:49:52 PM | Chg. -1.14 | Volume | Bid6:56:21 PM | Ask6:56:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 85.92USD | -1.31% | 6,259 Turnover: 275,390.97 |
85.83Bid Size: 1 | 86.01Ask Size: 2 | 8.66 bill.USD | 0.70% | 24.50 |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,517.1000 | 1,634.8000 | 1,959.3000 | 2,206.6000 | 2,601.6000 | ||||||
| Intangible Assets | 403.1000 | 443.4000 | 476.3000 | 431.3000 | 417.5000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 4,191.5000 | 4,512.9000 | 5,324.9000 | 5,497.3000 | 5,943.5000 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 472.1000 | 467.7000 | 506.1000 | 572.8000 | 680.3000 | ||||||
| Cash and Cash Equivalents | 54.4000 | 69.2000 | 94.8000 | 224 | 54.8000 | ||||||
| Current Assets | 702.2000 | 662.1000 | 755.8000 | 948.6000 | 921.4000 | ||||||
| Total Assets | 4,893.7000 | 5,175 | 6,080.7000 | 6,445.9000 | 6,864.9000 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 78.4000 | 90 | 94.6000 | 115 | 137.6000 | ||||||
| Long-term debt | 2,545.4000 | 2,478.6000 | 3,023.3000 | 3,250.6000 | 3,243.9000 | ||||||
| Liabilities to Banks | 2,545.4000 | 2,478.6000 | 3,023.3000 | 3,250.6000 | 3,243.9000 | ||||||
| Provisions | - | - | - | 51.8000 | 86.7000 | ||||||
| Liabilities | 3,469.1000 | 3,618 | 4,387.6000 | 4,475.9000 | 4,507.9000 | ||||||
| Share Capital | 1.1000 | 1.1000 | 1.1000 | 1.1000 | 1.1000 | ||||||
| Total Equity | 1,424.6000 | 1,557 | 1,693.1000 | 1,970 | 2,357 | ||||||
| Minority Interests | 242.9000 | 280.3000 | 340.9000 | 382 | 445.7000 | ||||||
| Total liabilities equity | 4,893.7000 | 5,175 | 6,080.7000 | 6,445.9000 | 6,864.9000 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3,971.4000 | 4,277.3000 | 4,605 | 4,644.4000 | 5,121.6000 | ||||||
| Depreciation (total) | 183.8000 | 199.7000 | 218.7000 | 243 | 256.6000 | ||||||
| Operating Result | - | - | - | - | - | ||||||
| Interest Income | 154.4000 | 147.3000 | 159.7000 | 184.2000 | 164.6000 | ||||||
| Income Before Taxes | 496.4000 | 493.2000 | 562.3000 | 472.6000 | 657.2000 | ||||||
| Income Taxes | 160.6000 | 118.9000 | 115.9000 | 103.8000 | 139.6000 | ||||||
| Minority Interests Profit | -79.1000 | -83.1000 | -87.1000 | -84.6000 | -105 | ||||||
| Net Income | 256.3000 | 292.3000 | 358.7000 | 284.2000 | 412.2000 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 657.2000 | 762.4000 | 635.3000 | 704.7000 | 715.8000 | ||||||
| Cash Flow from Investing Activities | -284.5000 | -424.5000 | -657.4000 | -407.5000 | -666.3000 | ||||||
| Cash Flow from Financing | -358.8000 | -321.2000 | 48.2000 | -145.9000 | -240.1000 | ||||||
| Decrease / Increase in Cash | 13.9000 | 16.7000 | 26.1000 | 151.3000 | -190.6000 | ||||||
| Employees | 29,370 | 30,060 | 31,570 | 43,178 | 43,400 | ||||||
